3 ms·
Probably because of this: Delandistrogene moxeparvovec was approved for medical use in the United States in June 2023.[3][7] It was developed by Sarepta Therape
by ygjb 1y ago
Probably because of this:
Delandistrogene moxeparvovec was approved for medical use in the United States in June 2023.[3][7] It was developed by Sarepta Therapeutics, together with Roche, and is manufactured by Catalent.[8]
- refurb 1y agoIt's not the same drug for the latest death this article is focused on... "Phase I study of SRP-9004".